
Rapid Micro Biosystems, Inc.: shareholders and insiders
Price
$0.74
November 18, 2026Market cap $33M
What Ploutos Investor adds for Rapid Micro Biosystems
Part of Ploutos Investor, €9.99 a month
- The full history: 6 fiscal years, from 2020
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
Notes on these figures
- The share price has fallen 57% since Aug 7, 2026, when the 10-Q these figures come from was filed ($1.73 then, $0.74 on Nov 17, 2026). The figures date from before that move.10-Q
- The interest the company pays is far more than the debt we can read would cost, so part of its borrowing is missing from the figures. We leave out the debt, net cash, enterprise value and the multiples built on them.
Insiders and their shares
Purchases and sales by officers and directors from Nov 18, 2025 to Jul 24, 2026, from their own Form 4 filings.
Bought on the market
–
nobody
Sold on the market
$1.1M
5 people
From Nov 18, 2025 to Nov 18, 2026, the days the chart shows. Change its range and the figures follow.
How the sales were made, as a share of their value
- Under a set plan0%
- The rest100%
By year
Insiders' open-market purchases (up) and sales (down), by value, since Nov 18, 2025, on a log scale: each gridline is ten times the last. From the SEC's quarterly data sets of Form 4 filings.
2026·no buys·sold $1.1M by 5 people
- 2025: no buys, no sales
- 2026: no buys, sold $1.1M by 5 people
- Jul 24, 2026Richard S KollenderDirectorKind
- Jul 24, 2026Richard S KollenderDirectorKind
- Jul 22, 2026Robert G. Spignesi Jr.PRESIDENT AND CEOKind
- May 29, 2026Inese LowensteinDirectorKind
- May 29, 2026Melinda Litherland PeiDirectorKind
- May 29, 2026Kirk MalloyDirectorKind
- May 29, 2026Sean M WirtjesCHIEF FINANCIAL OFFICERKind
- May 29, 2026Robert G. Spignesi Jr.PRESIDENT AND CEOKind
- May 21, 2026Kirk MalloyDirectorKind
- May 21, 2026Inese LowensteinDirectorKind
- May 21, 2026Melinda Litherland PeiDirectorKind
- May 21, 2026Richard S KollenderDirectorKind
- May 21, 2026Dafni BikaDirectorKind
- Mar 11, 2026Sean M WirtjesCHIEF FINANCIAL OFFICERKind
- Mar 11, 2026John J. Addington WilsonCHIEF OPERATING OFFICERKind
- Mar 10, 2026Robert G. Spignesi Jr.PRESIDENT AND CEOKind
- Feb 20, 2026Sean M WirtjesCHIEF FINANCIAL OFFICERKind
- Feb 20, 2026John J. Addington WilsonCHIEF OPERATING OFFICERKind
- Feb 19, 2026Robert G. Spignesi Jr.PRESIDENT AND CEOKind
- Feb 9, 2026Sean M WirtjesCHIEF FINANCIAL OFFICERKind
- Feb 9, 2026Robert G. Spignesi Jr.PRESIDENT AND CEOKind
- Feb 9, 2026John J. Addington WilsonCHIEF OPERATING OFFICERKind
- Feb 4, 2026Longitude Venture Partners II, L.P.Kind
- Feb 3, 2026Longitude Prime Partners, LLCKind
- Feb 2, 2026Longitude Prime Partners, LLCKind
| Date | Person | Kind | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jul 24, 2026 | Richard S KollenderDirector | 1,681 | $0.75 | $1.3K | Form 4 | |
| Jul 24, 2026 | Richard S KollenderDirector | 1,827 | $0.75 | $1.4K | Form 4 | |
| Jul 22, 2026 | Robert G. Spignesi Jr.PRESIDENT AND CEO | 1,402 | $0.75 | $1.1K | Form 4 | |
| May 29, 2026 | Inese LowensteinDirector | 12.8K | $1.96 | $25.0K | Form 4 | |
| May 29, 2026 | Melinda Litherland PeiDirector | 12.8K | $1.96 | $25.0K | Form 4 | |
| May 29, 2026 | Kirk MalloyDirector | 12.8K | $1.96 | $25.0K | Form 4 | |
| May 29, 2026 | Sean M WirtjesCHIEF FINANCIAL OFFICER | 12.8K | $1.96 | $25.0K | Form 4 | |
| May 29, 2026 | Robert G. Spignesi Jr.PRESIDENT AND CEO | 12.8K | $1.96 | $25.0K | Form 4 | |
| May 21, 2026 | Kirk MalloyDirector | 19.3K | – | – | Form 4 | |
| May 21, 2026 | Inese LowensteinDirector | 19.3K | – | – | Form 4 | |
| May 21, 2026 | Melinda Litherland PeiDirector | 19.3K | – | – | Form 4 | |
| May 21, 2026 | Richard S KollenderDirector | 19.3K | – | – | Form 4 | |
| May 21, 2026 | Dafni BikaDirector | 19.3K | – | – | Form 4 | |
| Mar 11, 2026 | Sean M WirtjesCHIEF FINANCIAL OFFICER | 7,480 | $4.32 | $32.3K | Form 4 | |
| Mar 11, 2026 | John J. Addington WilsonCHIEF OPERATING OFFICER | 9,603 | $4.32 | $41.5K | Form 4 | |
| Mar 10, 2026 | Robert G. Spignesi Jr.PRESIDENT AND CEO | 17.9K | $4.11 | $73.7K | Form 4 | |
| Feb 20, 2026 | Sean M WirtjesCHIEF FINANCIAL OFFICER | 17.3K | $3.92 | $67.6K | Form 4 | |
| Feb 20, 2026 | John J. Addington WilsonCHIEF OPERATING OFFICER | 5,403 | $3.92 | $21.2K | Form 4 | |
| Feb 19, 2026 | Robert G. Spignesi Jr.PRESIDENT AND CEO | 38.3K | $3.89 | $149.1K | Form 4 | |
| Feb 9, 2026 | Sean M WirtjesCHIEF FINANCIAL OFFICER | 6,027 | $3.78 | $22.8K | Form 4 | |
| Feb 9, 2026 | Robert G. Spignesi Jr.PRESIDENT AND CEO | 12.8K | $3.78 | $48.5K | Form 4 | |
| Feb 9, 2026 | John J. Addington WilsonCHIEF OPERATING OFFICER | 4,610 | $3.78 | $17.4K | Form 4 | |
| Feb 4, 2026 | Longitude Venture Partners II, L.P. | 49.0K | $3.88 | $190.1K | Form 4 | |
| Feb 3, 2026 | Longitude Prime Partners, LLC | 27.5K | $4.24 | $116.6K | Form 4 | |
| Feb 2, 2026 | Longitude Prime Partners, LLC | 27.5K | $4.25 | $116.9K | Form 4 |
From the Form 4s insiders file with the SEC within two business days of each trade. Before May 26, 2026 the table lists open-market purchases and sales only (no grants, option exercises or tax withholding), from the SEC's quarterly data sets. The 10b5-1 mark comes from the form's own box (since April 2023) or from a footnote of the filing that names the plan, where there is one.
Insiders and their shares
Every buy and sale by RPID's officers and directors from 2021 up to November 17, 2025, 5 more calendar years
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 3 years.
Major holders (over 5%)
Whoever comes to own more than 5% of a class of shares reports it to the SEC on Schedule 13D or 13G. Here is each holder's latest filing.
- Bain Capital Life Sciences Fund, L.P.with 1 more personClass A Common Stock, par value $0.01 per shareShare of class16.8%
- Longitude Capital Partners II, LLCwith 5 more personsClass A common stock, $0.01 par value per shareShare of class8.60%
- Armistice Capital, LLCwith 1 more personClass A common stock, $0.01 par value per shareShare of class7.29%
- Spignesi Robert G JrClass A Common Stock, $0.01 par value per shareShare of class6.30%
- Endeavour Medtech Growth II LPwith 2 more personsShare of class5.70%
| Holder | Kind of stake | Share of class | Shares | Filed | Filing |
|---|---|---|---|---|---|
| Bain Capital Life Sciences Fund, L.P.with 1 more personClass A Common Stock, par value $0.01 per share | 16.8% | 7.65M | Aug 14, 2026 | 13G/A | |
| Longitude Capital Partners II, LLCwith 5 more personsClass A common stock, $0.01 par value per share | 8.60% | 3.53M | May 15, 2026 | 13G/A | |
| Armistice Capital, LLCwith 1 more personClass A common stock, $0.01 par value per share | 7.29% | 3.33M | Aug 14, 2026 | 13G | |
| Spignesi Robert G JrClass A Common Stock, $0.01 par value per share | 6.30% | 2.65M | Aug 19, 2025 | 13D | |
| Endeavour Medtech Growth II LPwith 2 more persons | 5.70% | 2.26M | Feb 13, 2026 | 13G/A |
What the holders on a 13D state as their purpose
From Item 4 of the filing, in the holder's own words. It is the intention the holder states, not something that happened.
Spignesi Robert G Jr6.3%From the filing of Aug 19, 2025
The information set forth or incorporated by reference in Items 3 and 6 of this Statement is incorporated by reference into this Item 4. The Reporting Person intends to continuously review his investment in the Issuer and may in the future determine (1) to acquire additional securities of the Issuer, through open market purchases, private agreements or otherwise, (2) to dispose of all or a portion of the securities of the Issuer owned by him or (3) to take any other available course of action. Notwithstanding anything contained herein, the Reporting Person specifically reserves the right to change his intention with respect to any or all of such matters. In reaching any decision as to his…
From the filing of Aug 19, 2025
From the Schedule 13D and 13G filed with the SEC since Dec 18, 2024, when they became structured data. A holder who has filed nothing since then is not shown here. A 13D is updated within two business days of any material change, a 13G up to 45 days after the quarter of the change, so the shares are those of the filing. The large managers also appear in the 13Fs.
Well-known managers
Which of the about 30 investment managers we track held the shares at the quarter end, and what they changed from the quarter before.
- Citadel Advisors (Griffin)In the quarter
- Millennium Mgmt (Englander)In the quarter-16%
- Renaissance TechnologiesIn the quarter+13%
| Manager | Shares | In the quarter | Value | % of their portfolio |
|---|---|---|---|---|
| Citadel Advisors (Griffin) | 16.1K | $0 | 0.00% | |
| Millennium Mgmt (Englander) | 236.6K | -16% | $400.0K | 0.00% |
| Renaissance Technologies | 240.0K | +13% | $200.0K | 0.00% |
From the 13Fs managers file with the SEC up to 45 days after each quarter end. They show only long positions on that day, not short sales or what has changed since. No recent 13F: Pershing Square (Ackman), Scion (Burry).
Short interest
How many of the company's shares have been sold borrowed and not yet bought back, twice a month.
On Oct 15, 2026, 1.99% of its shares outstanding were held short, +4.1% since the report before.
- Shares held short
- 888.6K
- 1.99%
- Since the report before854.0K on Sep 30, 2026
- +4.1%
- 3.8
- 232.1K
- More days to cover thanof 4,578 US-listed companies with enough volume
- 46%
- Report date
- Oct 15, 2026
- Shares held short
- Oct 31, 2023: Shares held short 8,091
- Nov 15, 2023: Shares held short 6,779
- Nov 30, 2023: Shares held short 9,117
- Dec 15, 2023: Shares held short 15.1K
- Dec 29, 2023: Shares held short 38.1K
- Jan 12, 2024: Shares held short 168.5K
- Jan 31, 2024: Shares held short 131.9K
- Feb 15, 2024: Shares held short 103.7K
- Feb 29, 2024: Shares held short 90.2K
- Mar 15, 2024: Shares held short 80.3K
- Mar 28, 2024: Shares held short 57.9K
- Apr 15, 2024: Shares held short 60.9K
- Apr 30, 2024: Shares held short 53.2K
- May 15, 2024: Shares held short 38.8K
- May 31, 2024: Shares held short 19.5K
- Jun 14, 2024: Shares held short 26.9K
- Jun 28, 2024: Shares held short 35.5K
- Jul 15, 2024: Shares held short 21.0K
- Jul 31, 2024: Shares held short 11.5K
- Aug 15, 2024: Shares held short 79.6K
- Aug 30, 2024: Shares held short 45.3K
- Sep 13, 2024: Shares held short 70.2K
- Sep 30, 2024: Shares held short 39.9K
- Oct 15, 2024: Shares held short 17.6K
- Oct 31, 2024: Shares held short 70.4K
- Nov 15, 2024: Shares held short 44.0K
- Nov 29, 2024: Shares held short 31.1K
- Dec 13, 2024: Shares held short 58.2K
- Dec 31, 2024: Shares held short 43.6K
- Jan 15, 2025: Shares held short 113.6K
- Jan 31, 2025: Shares held short 132.3K
- Feb 14, 2025: Shares held short 134.4K
- Feb 28, 2025: Shares held short 406.5K
- Mar 14, 2025: Shares held short 1.18M
- Mar 31, 2025: Shares held short 1.61M
- Apr 15, 2025: Shares held short 1.44M
- Apr 30, 2025: Shares held short 1.41M
- May 15, 2025: Shares held short 985.2K
- May 30, 2025: Shares held short 737.5K
- Jun 13, 2025: Shares held short 688.0K
- Jun 30, 2025: Shares held short 515.6K
- Jul 15, 2025: Shares held short 409.5K
- Jul 31, 2025: Shares held short 344.8K
- Aug 15, 2025: Shares held short 338.1K
- Aug 29, 2025: Shares held short 340.6K
- Sep 15, 2025: Shares held short 384.7K
- Sep 30, 2025: Shares held short 378.5K
- Oct 15, 2025: Shares held short 322.7K
- Oct 31, 2025: Shares held short 310.7K
- Nov 14, 2025: Shares held short 301.5K
- Nov 28, 2025: Shares held short 238.8K
- Dec 15, 2025: Shares held short 161.3K
- Dec 31, 2025: Shares held short 178.9K
- Jan 15, 2026: Shares held short 178.6K
- Jan 30, 2026: Shares held short 166.1K
- Feb 13, 2026: Shares held short 177.6K
- Feb 27, 2026: Shares held short 216.9K
- Mar 13, 2026: Shares held short 317.4K
- Mar 31, 2026: Shares held short 377.5K
- Apr 15, 2026: Shares held short 543.9K
- Apr 30, 2026: Shares held short 808.9K
- May 15, 2026: Shares held short 659.8K
- May 29, 2026: Shares held short 748.4K
- Jun 15, 2026: Shares held short 614.0K
- Jun 30, 2026: Shares held short 738.5K
- Jul 15, 2026: Shares held short 842.3K
- Jul 31, 2026: Shares held short 825.8K
- Aug 14, 2026: Shares held short 843.8K
- Aug 31, 2026: Shares held short 869.4K
- Sep 15, 2026: Shares held short 940.4K
- Sep 30, 2026: Shares held short 854.0K
- Oct 15, 2026: Shares held short 888.6K
As brokers report them to the regulator twice a month, mid-month and at month end, published about eight business days later. A short position is shares sold borrowed and not yet bought back. The share count is the one the company's market value is figured on, from its filings. Days to cover is the shares held short over the average daily volume of the weeks between two reports.
Short sales in daily trading29.2% of the shares in the last 14 sessions' reported trades were short sales.
In the last 14 sessions, 29.2% of the shares in the reported trades were short sales, against 53.1% in the 14 before.
- Last 14 sessionsOct 29, 2026 – Nov 17, 2026
- 29.2%
- The 14 beforeOct 9, 2026 – Oct 28, 2026
- 53.1%
- Change
- -23.9 pts
- Short sales a dayon average, of 638.6K shares
- 186.2K
- More than atof 3,659 US-listed companies, same days
- 4%
- Median of alleight in ten from 34.6% to 63.7%
- 50.3%
- Short sales
- Oct 9, 2026: Short sales 45.2%
- Oct 12, 2026: Short sales 81.7%
- Oct 13, 2026: Short sales 50.4%
- Oct 14, 2026: Short sales 42.3%
- Oct 15, 2026: Short sales 72.5%
- Oct 16, 2026: Short sales 61.1%
- Oct 19, 2026: Short sales 56.5%
- Oct 20, 2026: Short sales 46.1%
- Oct 21, 2026: Short sales 59%
- Oct 22, 2026: Short sales 47%
- Oct 23, 2026: Short sales 72.8%
- Oct 26, 2026: Short sales 67.2%
- Oct 27, 2026: Short sales 28.6%
- Oct 28, 2026: Short sales 50.3%
- Oct 29, 2026: Short sales 51.4%
- Oct 30, 2026: Short sales 23.5%
- Nov 2, 2026: Short sales 35.1%
- Nov 3, 2026: Short sales 48.4%
- Nov 4, 2026: Short sales 68.1%
- Nov 5, 2026: Short sales 57.4%
- Nov 6, 2026: Short sales 36.7%
- Nov 9, 2026: Short sales 61.4%
- Nov 10, 2026: Short sales 49.8%
- Nov 11, 2026: Short sales 55.6%
- Nov 12, 2026: Short sales 53.2%
- Nov 13, 2026: Short sales 86.1%
- Nov 16, 2026: Short sales 23%
- Nov 17, 2026: Short sales 30.1%
This is not the number of shares sold short today: it measures short sales within each day's trading, and only trades made off the exchanges. Much of it is market makers, who sell shares they do not have to fill buyers' orders and cover soon after, so for a heavily traded stock the share is often around half.
What the insiders hold
The shares each insider reports holding after their latest trade (Form 4), for those who traded on the market in the last three years.
- Robert G. Spignesi Jr.PRESIDENT AND CEODirectly1.19M
- Sean M WirtjesCHIEF FINANCIAL OFFICERDirectly569.0K
- Richard S KollenderDirectorDirectly133.8K
- Melinda Litherland PeiDirectorDirectly100.7K
- Inese LowensteinDirectorDirectly70.7K
- Kirk MalloyDirectorDirectly70.7K
- Dafni BikaDirectorDirectly19.3K
| Person | Directly | Indirectly | After the trade of | Filing |
|---|---|---|---|---|
| Robert G. Spignesi Jr.PRESIDENT AND CEO | 1.19M | – | Jul 22, 2026 | Form 4 |
| Sean M WirtjesCHIEF FINANCIAL OFFICER | 569.0K | – | May 29, 2026 | Form 4 |
| Richard S KollenderDirector | 133.8K | – | Jul 24, 2026 | Form 4 |
| Melinda Litherland PeiDirector | 100.7K | – | May 29, 2026 | Form 4 |
| Inese LowensteinDirector | 70.7K | – | May 29, 2026 | Form 4 |
| Kirk MalloyDirector | 70.7K | – | May 29, 2026 | Form 4 |
| Dafni BikaDirector | 19.3K | – | May 21, 2026 | Form 4 |
A lower bound: it counts only the 7 officers and directors with a market trade since Nov 19, 2023. Anyone who neither bought nor sold since is not here, whatever they hold. The share is against the share count on the latest 10-K's cover.
The ETFs that hold it
Which of the 345 US equity ETFs we track hold the stock, and at what weight, from the funds' N-PORT filings.
- IWCiShares Micro-Cap ETFWeight in the fund0.01%
- VXFVanguard Extended Market Index FundWeight in the fund0.00%
- DFASDimensional U.S. Small Cap ETFWeight in the fund0.00%
- VTIVanguard Total Stock Market Index FundWeight in the fund0.00%
4 of the 345 ETFs we track, not of every ETF on the market. The ten largest weights. Positions as each fund filed them in its latest N-PORT.
Institutional investors by quarter
Every manager that reports positions to the SEC (Form 13F), quarter by quarter: how many hold the stock, how many shares and dollars between them, and who entered, left, added or trimmed during the quarter.
- Managers
- Q3 2025: Managers 29
- Q4 2025: Managers 42
- Q1 2026: Managers 46
- Q2 2026: Managers 34
Institutional investors by quarter
The fund managers holding RPID, quarter by quarter, from Q3 2021 to Q2 2025, 16 more quarters
Part of Ploutos Investor, €9.99 a month
Sign in with a free account to see the last 12 quarters.
Q2 2026: 34 managers held 17.52M shares, worth $30M. During the quarter 5 opened a position, 17 closed one, 8 added and 12 trimmed.
The largest holders, Q2 2026
- Bain Capital Life Sciences InvestorsIn the quarter
- Armistice CapitalIn the quarter
- ABG-WTT Global Life Science Capital Partners GPIn the quarter
- Vanguard Capital ManagementIn the quarter
- Evernest Financial AdvisorsIn the quarter+17%
- Advent InternationalIn the quarter-31%
- Essex Investment ManagementIn the quarter-59%
- Millennium Mgmt (Englander)In the quarter-16%
- Geode Capital ManagementIn the quarter-7.7%
- Renaissance TechnologiesIn the quarter+68%
| Manager | Shares | In the quarter | Value |
|---|---|---|---|
| Bain Capital Life Sciences Investors | 8.43M | $15M | |
| Armistice Capital | 3.33M | $5.8M | |
| ABG-WTT Global Life Science Capital Partners GP | 1.85M | $3.2M | |
| Vanguard Capital Management | 982.0K | $1.7M | |
| Evernest Financial Advisors | 506.0K | +17% | $875.4K |
| Advent International | 379.8K | -31% | $657.0K |
| Essex Investment Management | 362.7K | -59% | $627.5K |
| Millennium Mgmt (Englander) | 236.6K | -16% | $409.3K |
| Geode Capital Management | 228.0K | -7.7% | $394.7K |
| Renaissance Technologies | 212.1K | +68% | $366.9K |
From the SEC's Form 13F data sets, Q3 2025 to Q2 2026: the long positions of every manager with more than $100 million under management, as filed up to 45 days after each quarter end. Short positions and options are not in them. Shares as reported each quarter, not adjusted for splits. The stock is matched by its CUSIP, through the SEC's fails-to-deliver files.
Pay against performance, the say-on-pay vote, buybacks by quarter and trading plans are read for S&P 500 companies only.
The full analysis
What do Rapid Micro Biosystems's filings show?
Who buys and sells is one part of Rapid Micro Biosystems's picture. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Have RPID's insiders bought or sold?
From May 26, 2026 to Jul 24, 2026 Rapid Micro Biosystems's insiders reported no purchase or sale of shares on the market.
Which well-known managers hold RPID?
3 of the managers we track held the shares on Sep 30, 2026. The largest position was Millennium Mgmt (Englander)'s, worth $400.0K.
Is every insider transaction a purchase or a sale?
No. Many are part of their pay: share awards, option exercises and shares the company keeps for the tax. Only code P is a purchase with their own money, and code S a sale on the market.
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.